Gastroprotective activity
Ethanol-induced gastric ulcer model in Wistar rats.
Wistar rats received Bacospore® (100 or 200 mg/kg) or ranitidine (20 mg/kg) orally for 7 days. After 24 h of fasting, gastric ulcers were induced with absolute ethanol (1 mL/200 g, p.o.). Gastric lesions, ulcer index, ulcer protection, and histopathology were assessed.
Marked gastroprotection was observed, with significant reduction in ulcer index and ~80.4% inhibition of ulcer formation, likely through enhancement of mucosal defence and preservation of epithelial integrity.
Antidiarrheal activity
Castor oil-induced diarrhoea model in male Wistar rats.
Bacospore® was administered at 100 and 200 mg/kg, with loperamide (1 mg/kg) as the standard. Wet stool weight recorded at 2 and 4 hours.
26.6% inhibition of diarrhoea (loperamide: 42.2%) at 200 mg/kg, with wet stool weight at 4 h reduced to 1.16 ± 0.24 g vs. 1.58 ± 0.20 g in the control group.
In-vitro collagenase inhibition
In-vitro, enzyme-based biochemical assay.
Bacospore® tested at 12.5–200 µg/mL with EDTA as a positive control.
Showed dose-dependent collagenase inhibition, with 85.40% inhibition at 200 µg/mL.
In-vitro cholesterol reduction
In-vitro bile salt hydrolase (BSH) enzyme assay for cholesterol-lowering activity.
Bacospore® concentrations of 31.25–1,000 µg/mL were tested, with residual cholesterol measured enzymatically using bile salts as the reference.
Concentration-dependent cholesterol inhibition, increasing from 38.77% at 125 µg/mL to 97.72% at 1,000 µg/mL, compared with 99.41% for the bile-salt reference.
In-vitro antioxidant & cell line studies
3T3-L1 preadipocyte cells and cell-free enzyme assays
MTT assay for cell viability, Oil Red O staining and PPAR-γ ELISA for adipogenesis, DPPH assay for antioxidant activity, and α-amylase and α-glucosidase inhibition assays.
Bacillus coagulans showed efficient antioxidant activity, with an IC₅₀ of 54.19 µg/mL. It maintained cell viability across the tested concentration range (7.8–1,000 µg/mL), with viability remaining around or above 100% at most concentrations. It also showed moderate anti-adipogenic and α-amylase inhibitory activity.
Publications.
- Dhabadi P. et al. Evaluation of Antidiarrheal, Antiulcer, Anti-Collagenase and Cholesterol-Lowering Activity of Heyndrickxia coagulans MTCC 25308. International Journal of Basic & Clinical Pharmacology, in press.
- Hussain Z.F. et al. Strain-Specific Modulation of Oxidative Stress, Carbohydrate Metabolism and Adipogenesis by Probiotic Bacillus spp. in 3T3-L1 Cells. International Journal of Basic and Applied Sciences. 2026;15(2):105-110.

